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Dear Editor,
Lithium has many adverse effects limiting its prescription1. Creatine 
kinase (CK) is released when skeletal muscle cells are damaged. 
Psychiatric patients with remarkable CK elevations commonly 
indicate to two life-threatening physical conditions, rhabdomyolysis 
and neuroleptic malignant syndrome (NMS). Lithium use is related 
to rhabdomyolysis and NMS2-4, but the association of lithium and 
asymptomatic CK elevation had not been reported.
Mr. Y is a 17-year-old man presenting with hyperactivity and 
agitation when he was brought to emergency department. He had 
manic symptoms including elevated mood, decreased need of sleep, 
grandiosity, hypertalkativeness lasting for one week. Upon emergency 
room visit his blood test showed increased levels of GOT/GPT 
(208/63 U/L) and CK (8697 U/L). He was admitted to pediatric ward 
due to rhabdomyolysis and then transferred to psychiatric ward after 
the condition became stable (CK was 1215 U/L at the transferring 
day). He was treated with quetiapine first but manic symptoms were 
still active despite the dosage reached to 600 mg/day. His serum CK 
level decreased to 644 U/L after two-week admission. We had tried 
to add mood stabilizers for combination treatment, but valporic 
acid was discontinued due to allergic reaction and carbamazepine 
was contraindicated because of his positive HLA-B1502 genotype. 
Then, we prescribed lithium for him. We started with 300 mg/day 
and gradually titrated to 900 mg/day. He had obvious response to 
lithium (Young Mania Rating Scale total score from 43 to 12 after 
the dose reaching 900 mg/day). When monitoring his laboratory 
parameters and serum lithium concentration, we found the serum CK 
level increased again after lithium treatment. Further, his serum CK 
levels were positively correlated to serum lithium levels. Lithium was 
then discontinued and his serum CK level returned to baseline (the 
time trends are shown in Figure1). During the period of abnormal 
CK level, he did not have hyperactivity and other physical complaints, 
and his associated laboratory data were unremarkable (normal liver, 
renal function and urine globulin).
Lithium interferences with the collecting tubules and suppress 
antidiuretic hormone stimulation, which makes its polyuria and 
polydipsia side effects1. Another case report assumed lithium might 
induce hyperosmolar state3. These conditions might induce elevated 
CK levels and even rhabdomyolysis. However, our patient did not 
have the above states. Besides, the positive correlation between 
lithium and CK concentration was not mentioned before. The 
concentration-dependent relationship between lithium and CK needs 
further investigations.
Massive Asymptomatic Creatine Kinase Elevation (MACKE) has 
been discussed in youths using antipsychotics4. The article concluded 
that MACKE is harmless and intensive CK monitor is unnecessary. 
Whether lithium induced CK elevation is harmless like MACKE or 
not need more studies to confirm. Furthermore, Gosling et al. found 
the elevation of serum CK may indicate mania is under controlled5. 
Our patient also showed obvious response during CK elevation. But 
using serum CK level to detect lithium treatment efficacy is lack of 
well-established evidence. Whether lithium induced asymptomatic 
serum CK elevation is harmful, harmless, or treatment response 
predictive needs more explorations.
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In addition, studies revealed that higher CK level was found in 
the manic patients compared with the depressed ones and the lack 
of correlations between CK level and motor activity6. Further studies 
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